Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 5 of 5 entries
View as:

Study of the Safety and Efficacy of AMT-101 in Subjects With Pouchitis

Phase: N/A Priority: Normal
NCT ID: NCT04741087 Org: User:
Start: 02/05/21 End: 04/22/22 Due: 04/22/23

SAD/MAD Study in Healthy Subjects and Adults With UC to Evaluate Safety, Tolerability, PK, PD of AMT-101

Phase: N/A Priority: Normal
NCT ID: NCT04224857 Org: User:
Start: 04/01/19 End: 04/30/20 Due: 04/30/21

Study of the Efficacy and Safety of AMT-101 in Subjects With Ulcerative Colitis (LOMBARD)

Phase: N/A Priority: Normal
NCT ID: NCT04583358 Org: User:
Start: 08/26/20 End: 12/31/22 Due: 12/31/23

Study of the Efficacy and Safety of AMT-101 in Combination With Adalimumab in Subjects With Ulcerative Colitis (MARKET)

Phase: N/A Priority: Normal
NCT ID: NCT05372939 Org: User:
Start: 02/05/21 End: 07/13/22 Due: 07/13/23

SAD Study to Assess the Safety, Tolerability, PK, and In-Vivo Performance of AMT-126 in Healthy Male and Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05476107 Org: User:
Start: 02/26/21 End: 03/26/22 Due: 03/26/23